São Paulo · Latin America desk
Latin America rewards access economics, not imported playbooks.
Large private payer markets, constrained public systems and rising pharma import substitution. We look for companies that lower cost per patient while holding margin.
Focus
Access · Diagnostics · Supply
Cheque
US$10M+
Markets
BR · MX · CL · CO
Time zone
BRT (UTC−3)
What we look for
Diagnostics and specialty care networks with payer contracts and defensible cost-per-episode advantages.
Pharma supply and generics manufacturing serving import-substitution policy, particularly with Indian technology partners.
How we underwrite currency and policy risk
We model local-currency revenue against hard-currency capital cost explicitly, and avoid assets whose returns depend on a single administration's policy.
Frequently asked questions
- Is Latin America a core OceansGled market?
- It is an opportunistic market. We invest where an Indian or Asian manufacturing partnership creates a structural cost advantage.
- Which LatAm countries do you cover?
- Brazil, Mexico, Chile and Colombia primarily.
- What is the minimum cheque?
- US$10 million, Series A or B, with follow-on reserves.